[1]
2023. Pituitary Macroadenoma Grading Using Magnetic Resonance Imaging: A Sipap Classification Study. Journal of Pharmaceutical Negative Results. (Mar. 2023), 3503–3511. DOI:https://doi.org/10.47750/pnr.2023.14.03.435.